Skip to content

Seaport Therapeutics SPTX Operating Lease Liabilities

Operating Lease Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$37.6M+24.7%
Repligen logo
RepligenRGEN
$119.96M-13.7%
LKQ logo
LKQLKQ
$1.14B-5.4%
AppFolio logo
AppFolioAPPF
$31.98M-12.0%
CHE
ChemedCHE
$104.45M+2.3%
Boyd Gaming logo
Boyd GamingBYD
$536.75M-10.3%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's operating lease liabilities?
Seaport Therapeutics (SPTX) reported operating lease liabilities of $3.74M in Q1 2026.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.